Found: 2
Select item for more details and to access through your institution.
Pharmacokinetic Data of Dolutegravir in Second-line Treatment of Children With Human Immunodeficiency Virus: Results From the CHAPAS4 Trial.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 9, p. 1312, doi. 10.1093/cid/ciad346
- By:
- Publication type:
- Article
First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 6, p. 875, doi. 10.1093/cid/ciad267
- By:
- Publication type:
- Article